Order Article Reprints

Elhasasna H, Khan R, Bhanumathy KK, Vizeacoumar FS, Walke P, Bautista M, Dahiya DK, Maranda V, Patel H, Balagopal A, et al. A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers. Cells. 2022; 11(14):2246. https://doi.org/10.3390/cells11142246

Elhasasna, Hussain, Raymond Khan, Kalpana K. Bhanumathy, Frederick S. Vizeacoumar, Prachi Walke, Maricris Bautista, Dinesh K. Dahiya, Vincent Maranda, Hardikkumar Patel, Amrutha Balagopal, and et al. 2022. "A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers" Cells 11, no. 14: 2246. https://doi.org/10.3390/cells11142246

Elhasasna, H., Khan, R., Bhanumathy, K. K., Vizeacoumar, F. S., Walke, P., Bautista, M., Dahiya, D. K., Maranda, V., Patel, H., Balagopal, A., Alli, N., Krishnan, A., Freywald, A., & Vizeacoumar, F. J. (2022). A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers. Cells, 11(14), 2246. https://doi.org/10.3390/cells11142246